• Indian Indices
  • Global Indices
  • Commodities
  • Currency
Sensex
  • Sensex
  • Nifty
{{x.close_price| number:2}} {{x.netchg| number:2}} ({{x.perchg | number:2}}%)
Open - {{x.open | number:2}}
Prev Close - {{x.prevclose|number:2}}
Today's High - {{x.high|number:2}}
Today's Low - {{x.low|number:2}}
Advances/Declines (30 Companies)
  • 1D
  • 1W
  • 1M
  • 1Yr
  • 5Yr
{{x.upd_time}}
FTSE 100
  • FTSE 100
  • DJIA
  • NIKKEI 225
  • HANG SENG
{{x.Date}}
{{x.close| number:2}} {{x.Chg | number:2}} ({{x.PChg | number:2}}%)
Open - {{x.close | number:2}}
Prev Close - {{x.PrevClose|number:2}}
Gold
  • Gold
  • Silver
  • Crude Oil
  • Copper
{{x.Trd_Date}} ( {{x.Time}} )
{{x.ClosePrice| number:2}} {{x.change| number:2}} ({{x.perchange | number:2}}%)
Exchange - MCX
Open - {{x.Open|number:2}}
Exp Date - {{x.Exp_Date}}
Today's High - {{x.High|number:2}}
Prev. Close - {{x.PrevClose|number:2}}
Today's Low - {{x.Low|number:2}}
USDINR
  • USDINR
  • GBPINR
  • EURINR
  • JPYINR
{{x.Lasttrdtime}} ( {{x.Time}} )
{{x.ltp| number:2}} {{x.PriceDiff| number:2}} ({{x.PerChange | number:2}}%)
Exchange - NSE
Open - {{x.Open|number:2}}
Exp Date - {{x.Expirydate}}
Today's High - {{x.High|number:2}}
Prev. Close - {{x.PrevPrice|number:2}}
Today's Low - {{x.Low|number:2}}
As On 24-Mar-2023 EOD, Market Closed
SENSEX
57,527.10
-398.18 (-0.69%)
NIFTY
16,945.05
-131.85 (-0.77%)
    No Companies Visited

Back to news list
  • Sun Pharma acquires three brands from Aksigen

    The drug maker announced that it has acquired three brands Disperzyme, Disperzyme-CD, Phlogam from Aksigen Hospital Care (Aksigen).

    Aksigen Hospital Care is a Mumbai-based research driven healthcare entity with more than two decades of experience in the healthcare field. All the brands are approved by the drugs controller general of India (DCGI) for post-operative inflammation in patients undergoing minor surgery and dental procedures. Disperzyme and phlogam tablet is a pain-relieving medicine, used in the treatment of various conditions such as fever, headache, arthritis-related pain, menstrual cramps, and toothache. Disperzyme and Phlogam are the first enzyme-bioflavonoid combination of Trypsin, Bromelain and Rutoside (TBR) to complete a clinical study in India and get DCGI approval. The brands were registered and launched in India by Aksigen in 2013.

    The overall market of proteolytic enzyme for healing, pain and edema in India is around Rs 500 crore (as per IQVIA data MAT Nov 2022).

    Kirti Ganorkar, CEO-India business, Sun Pharma, said, “The addition of Disperzyme and Phlogam further strengthens our anti-inflammatory portfolio. This systemic enzyme therapy combination is being used to control edema and it speeds-up the healing process. In a comparative clinical trial in India, the brands provided significantly better control and resolution of post-operative pain and inflammation.”

    Sun Pharmaceuticals Industries is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations and Active Pharmaceutical Ingredients (APIs).

    The company's consolidated net profit rose 10.5% to Rs 2,262.22 crore on 13.1% jump in net sales to Rs 10,809.19 crore in Q3 FY22 over Q3 FY22.

    The scrip rose 0.78% to Rs 1051.70 on the BSE.



    Back to news list
Previous Stories :
More






Hot Pursuit News

Quick Links

Market Statistics

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

The power of the database is harnessed by our fired-up reporters to generate interesting ideas. The reader-friendly presentation of the idea, supplemented by relevant data and information, can be accessed online through Capita Telefolio and Telefolio Gold. These ideas are used by individual investors as well as institutional investors to do further research and stay ahead.

Capital Market Publishers India Pvt. Ltd.

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071.
91-22-25229720
9769005430
Kindly note www.capitalmarket.com does not send any mobile SMS, whatsapp or twitter messages
giving any kind of stock recommendations.
For Capital Market Magazine queries mail to : subscription@capitalmarket.com
For Capital Market Online Products related queries mail to : financeshop@capitalmarket.com
For any other Capital Market Website related Queries mail to : info@capitalmarket.com
To advertise on Capital Market Websites & Capital Market Fortnightly magazine mail to : advt@capitalmarket.com
Flash News 25-Mar-2023
  •  ( 17:07) Reliance Industries appoints Srikanth Venkatachari as CFO  
  •  ( 16:50) Shriram Finance to raise $150 mln via senior secured notes  
  •  ( 15:33) Tata Steel acquires stake in subsidiary for Rs 10-cr  
  •  ( 14:51) Paisalo Digital board to mull fund raising on Mar 29  
  •  ( 14:40) Alembic Pharma karkhadi facility gets two USFDA observations  
  •  ( 13:05) Godawari Power resumes operation of sponge iron plant  
  •  ( 12:09) Tube Invest, Premji Invest tieup to acquire Lotus Surgicals  
  •  ( 12:05) IOB raises Rs 1,000 crore via issue of non-convertible bonds  
  •  ( 11:05) BEL secures orders worth Rs 4,300-cr from Indian Army, Indian Navy  
  •  ( 11:04) Sun Pharma to acquire 60% stake Vivaldis Health for Rs 143 crore  
  •  ( 11:03) Centre hikes DA by 4% for govt employees, pensioners  
  •  ( 09:36) RBI imposes Rs 30 lakh penalty on Karur Vysya Bank  
Show News
24 March 2023 00:00
2798.70
(0.05 %)
840.50
(-0.97 %)
5650.65
(-3.19 %)
1241.05
(-3.81 %)
762.25
(-0.04 %)
2563.55
(-0.16 %)
1051.55
(-1.36 %)
1561.75
(-0.06 %)
2480.50
(-0.19 %)
852.05
(-0.45 %)
1010.20
(-0.78 %)
1380.45
(0.43 %)
378.70
(-0.39 %)
1691.55
(0.74 %)
2163.10
(-1.95 %)
1150.20
(-1.25 %)
8236.25
(-1.24 %)
18951.65
(-0.38 %)
172.70
(-1.06 %)
222.45
(0.18 %)
2203.50
(-1.96 %)
505.60
(-1.38 %)
972.80
(-0.46 %)
416.25
(-0.68 %)
102.15
(-2.58 %)
3121.45
(-0.08 %)
1101.55
(0.16 %)
2492.95
(-0.99 %)
7401.35
(-0.14 %)
361.55
(0.00 %)
Sensex 5min and Nifty 15min delayed as on .
Show Ticker
Rotate your device

Rotate your device

For the best experience please go back to portrait mode.